Nothing Special   »   [go: up one dir, main page]

ATE170521T1 - 1-methyl-carbapenemderivate, deren herstellung und verwendung als antibiotika - Google Patents

1-methyl-carbapenemderivate, deren herstellung und verwendung als antibiotika

Info

Publication number
ATE170521T1
ATE170521T1 AT92305130T AT92305130T ATE170521T1 AT E170521 T1 ATE170521 T1 AT E170521T1 AT 92305130 T AT92305130 T AT 92305130T AT 92305130 T AT92305130 T AT 92305130T AT E170521 T1 ATE170521 T1 AT E170521T1
Authority
AT
Austria
Prior art keywords
antibiotics
methyl
preparation
carbapenem derivatives
compounds
Prior art date
Application number
AT92305130T
Other languages
English (en)
Inventor
Isao Kawamoto
Rokuro Endo
Masao Miyauchi
Katsuhiko Watanabe
Eiji Nakayama
Hiroshi Yasuda
Satoshi Ohya
Yukio Utsui
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of ATE170521T1 publication Critical patent/ATE170521T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
AT92305130T 1991-06-04 1992-06-04 1-methyl-carbapenemderivate, deren herstellung und verwendung als antibiotika ATE170521T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP13154591 1991-06-04
JP34573791 1991-12-27
JP3052192 1992-02-18
JP9128392 1992-04-10

Publications (1)

Publication Number Publication Date
ATE170521T1 true ATE170521T1 (de) 1998-09-15

Family

ID=27459269

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92305130T ATE170521T1 (de) 1991-06-04 1992-06-04 1-methyl-carbapenemderivate, deren herstellung und verwendung als antibiotika

Country Status (21)

Country Link
EP (1) EP0518558B1 (de)
JP (1) JP2559949B2 (de)
KR (1) KR100247855B1 (de)
CN (1) CN1030767C (de)
AT (1) ATE170521T1 (de)
AU (1) AU651887B2 (de)
CA (1) CA2070305A1 (de)
CZ (1) CZ167792A3 (de)
DE (1) DE69226815T2 (de)
DK (1) DK0518558T3 (de)
ES (1) ES2120992T3 (de)
FI (1) FI101226B (de)
HK (1) HK1011980A1 (de)
HU (2) HU218289B (de)
IE (1) IE921796A1 (de)
IL (1) IL102093A (de)
MX (1) MX9202670A (de)
NO (1) NO302475B1 (de)
NZ (1) NZ243022A (de)
RU (1) RU2093514C1 (de)
TW (1) TW203612B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712267A (en) * 1991-06-04 1998-01-27 Sankyo Company,. Limited Carbapenem derivatives, their preparation and their use as antibiotics
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CZ290002B6 (cs) * 1992-03-11 2002-05-15 Sankyo Company Limited Antimikrobiální karbapenemové deriváty, způsob výroby a farmaceutický prostředek
GB9304156D0 (en) * 1992-03-26 1993-04-21 Zeneca Ltd Antibiotic compounds
EP0581502B1 (de) * 1992-07-21 1998-10-21 Zeneca Limited Antibiotische carbapenemverbindungen
CA2099818A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
AU4912393A (en) * 1993-06-15 1994-12-22 Dong Kook Pharmaceutical Co., Ltd. 1-beta-methyl-2-thiolic carbapenem derivatives
JP3848693B2 (ja) * 1994-07-06 2006-11-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 新規カルバペネム誘導体
GB9515975D0 (en) 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
DE69623497T2 (de) * 1995-12-21 2003-05-28 Sankyo Co., Ltd. 1-methylcarbapenem-derivate
ES2180977T3 (es) * 1996-04-26 2003-02-16 Sankyo Co Un derivado de 1-metilcarbapenem.
AU4020897A (en) 1996-08-17 1998-03-06 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
AU1415500A (en) * 1998-12-07 2000-06-26 Sankyo Company Limited 1-methylcarbapenem derivatives
GB9930318D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930317D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
DE60237528D1 (de) 2001-09-14 2010-10-14 High Point Pharmaceuticals Llc Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative
US6673829B2 (en) 2001-09-14 2004-01-06 Novo Nordisk A/S Aminoazetidine,-pyrrolidine and -piperidine derivatives
CN101367814B (zh) * 2007-06-28 2010-12-15 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰哌啶取代的培南衍生物
US8236792B2 (en) * 2008-05-23 2012-08-07 Janssen Pharmaceutica Nv Substituted pyrrolidine amides as modulators of the histamine H3 receptor
US11180504B2 (en) 2016-03-16 2021-11-23 Orchid Pharma Ltd. Substituted carbapenems for the treatment of bacterial infections

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
ES2051700T3 (es) * 1986-03-27 1994-07-01 Sumitomo Pharma Un proceso para la preparacion de un compuesto beta-lactama.
CA2036163C (en) * 1990-02-14 2001-06-19 Makoto Sunagawa Novel beta-lactam compounds and their production
NO178498C (no) * 1990-02-23 1996-04-10 Sankyo Co Analogifremgangsmåte ved fremstilling av terapeutisk aktive karbapenemderivater
TW198034B (de) * 1990-03-27 1993-01-11 Manyu Seiyaku Kk
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
CZ290002B6 (cs) * 1992-03-11 2002-05-15 Sankyo Company Limited Antimikrobiální karbapenemové deriváty, způsob výroby a farmaceutický prostředek

Also Published As

Publication number Publication date
AU1739092A (en) 1993-03-11
EP0518558A1 (de) 1992-12-16
CA2070305A1 (en) 1992-12-05
NO922185L (no) 1992-12-07
NO302475B1 (no) 1998-03-09
KR100247855B1 (ko) 2000-05-01
JP2559949B2 (ja) 1996-12-04
IL102093A (en) 1996-12-05
RU2093514C1 (ru) 1997-10-20
IE921796A1 (en) 1992-12-16
HUT61551A (en) 1993-01-28
CN1069494A (zh) 1993-03-03
KR930000515A (ko) 1993-01-15
NZ243022A (en) 1993-07-27
DE69226815D1 (de) 1998-10-08
IL102093A0 (en) 1993-01-14
MX9202670A (es) 1993-01-01
AU651887B2 (en) 1994-08-04
HU211822A9 (en) 1995-12-28
HK1011980A1 (en) 1999-07-23
DK0518558T3 (da) 1999-05-31
FI922561A0 (fi) 1992-06-03
EP0518558B1 (de) 1998-09-02
FI101226B1 (fi) 1998-05-15
HU9201871D0 (en) 1992-08-28
NO922185D0 (no) 1992-06-03
FI922561A (fi) 1992-12-05
FI101226B (fi) 1998-05-15
CN1030767C (zh) 1996-01-24
JPH05339269A (ja) 1993-12-21
DE69226815T2 (de) 1999-05-20
CZ167792A3 (en) 1995-12-13
TW203612B (de) 1993-04-11
ES2120992T3 (es) 1998-11-16
HU218289B (en) 2000-07-28

Similar Documents

Publication Publication Date Title
ATE170521T1 (de) 1-methyl-carbapenemderivate, deren herstellung und verwendung als antibiotika
DE3881408D1 (de) Thiazolidinon-derivate, ihre herstellung und ihre verwendung.
FI901530A0 (fi) Menetelmä immunomoduloivien atsaspiraanien valmistamiseksi
AU591780B2 (en) Benzo{b}thiophene- and benzo{b}furancarboxamide derivatives their preparation, and pharmaceutical compositions containing them
HU9401943D0 (en) Process for producing amide and urea derivatives and compositions containing them
ES2077070T3 (es) Intermedio de sintesis de 2-alquiniladenosina, produccion de dicho intermedio, produccion de 2-alquiniladenosina a partir de dicho intermedio, y derivado de 2-alquiniladenosina estable.
DE3777852D1 (de) Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
DE69122866D1 (de) Herstellung von substituierten piperidinen
PL263885A1 (en) Method of obtaining novel derivatives of dihydrobenzofurane and chromate carbonamide
ATE138571T1 (de) Verwendung von dioxabicyclo (3.3.0>octane derivaten zur herstellung eines arzneimittels zur hemmung des cholesterinmetabolismus.
ATE208760T1 (de) 3-amino-2-mercaptobenzoesäure-derivate und verfahren zu ihrer herstellung
DE68903680D1 (de) 6-phenyl-3-piperazinylalkyl-1h,3h-pyrimidindion-2,4-derivate, deren herstellung und verwendung als heilmittel.
IL94027A0 (en) Diaminoethylene compounds
ATE78100T1 (de) Bifunktionelle haptene, verfahren zu ihrer herstellung und ihre verwendung.
MX170732B (es) Composicion de derivados de succinimida y su uso
WO1991000729A3 (en) Bis-dioxopiperazines, and their use as protecting agents
DE69625795D1 (de) Thiazolidinedionderivate mit antidiabetischen, hypolipidämischen und antihypertensiven Eigenschaften, Verfahren zu deren Herstellung und pharmazeutischen Zusammenstellungen, die sie enthalten
DE68905363D1 (de) Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
ATE159021T1 (de) Verfahren zur herstellung von penem derivaten und zwischenprodukte zu dieser herstellung
DE3777464D1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
DE3673129D1 (de) Alkylcarbonsaeureamide von pyridinalkylaminen, ihre herstellung und ihre verwendung als arzneimittel.
DE68926016D1 (de) Halogeno-4-Methylpyrazole und Verfahren zu ihrer Herstellung
EP0367671A3 (de) Beta-D-phenylthioxyloside, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
FR2456102B1 (de)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee